1-10 of 10
Keywords: LRRK2
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Biochem Soc Trans (2021) 49 (5): 2063–2072.
Published: 08 September 2021
...Giovanni Piccoli; Mattia Volta Parkinson's disease (PD) is an age-related neurodegenerative disorder, clinically characterized by bradykinesia, rigidity, and resting tremor. Leucine-Rich Repeat Kinase 2 (LRRK2) is a large, multidomain protein containing two enzymatic domains. Missense mutations...
Articles
Biochem Soc Trans (2021) 49 (3): 1375–1384.
Published: 07 May 2021
...Alice Filippini; Massimo Gennarelli; Isabella Russo Missense mutations in the leucine-rich repeat kinase-2 ( LRRK2 ) gene represent the most common cause of autosomal dominant Parkinson's disease (PD). In the years LRRK2 has been associated with several organelles and related pathways in cell...
Articles
Biochem Soc Trans (2019) 47 (6): 1581–1595.
Published: 26 November 2019
...Rebecca L. Wallings; Malú G. Tansey Mutations in the leucine-rich-repeat kinase 2 ( LRRK2 ) gene are associated with familial and sporadic cases of Parkinson's disease but are also found in immune-related disorders such as inflammatory bowel disease, tuberculosis and leprosy. LRRK2 is highly...
Articles
Biochem Soc Trans (2019) 47 (3): 827–838.
Published: 13 May 2019
...Tiago Fleming Outeiro; Kirsten Harvey; Antonio Dominguez-Meijide; Ellen Gerhardt The identification of genetic forms of Parkinson's disease (PD) has tremendously expanded our understanding of the players and mechanisms involved. Mutations in the genes encoding for alpha-synuclein (aSyn), LRRK2...
Articles
Biochem Soc Trans (2019) 47 (2): 663–670.
Published: 05 March 2019
...Shijie Wang; Andrew B. West Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a frequent genetic cause of late-onset Parkinson's disease (PD) and a target for therapeutic approaches. LRRK2 protein can influence vesicle trafficking events in the cytosol, with action both in endosomal...
Articles
Biochem Soc Trans (2019) 47 (1): 197–207.
Published: 21 December 2018
...Kirsten Harvey; Tiago F. Outeiro Parkinson's disease (PD) is a common late-onset neurodegenerative disorder known primarily for its motor features. Mutations and risk variants in LRRK2 cause familial and idiopathic forms of PD. Mutations segregating with disease are found in the LRRK2 GTPase...
Articles
Biochem Soc Trans (2018) 46 (6): 1707–1712.
Published: 22 November 2018
...Suzanne R. Pfeffer Leucine-rich repeat kinase 2 (LRRK2) is mutated in familial Parkinson's disease, and pathogenic mutations activate the kinase activity. A tour de force screen by Mann and Alessi and co-workers identified a subset of Rab GTPases as bona fide LRRK2 substrates. Rab GTPases...
Articles
Biochem Soc Trans (2017) 45 (1): 207–212.
Published: 15 February 2017
...Jean-Marc Taymans; Eugénie Mutez; Matthieu Drouyer; William Sibran; Marie-Christine Chartier-Harlin Leucine-rich repeat kinase 2 (LRRK2) is a complex signalling protein that is a key therapeutic target, particularly in Parkinson's disease (PD). In addition, there is now evidence showing that LRRK2...
Articles
Biochem Soc Trans (2017) 45 (1): 261–267.
Published: 15 February 2017
...Elisa Greggio; Luigi Bubacco; Isabella Russo Evidence indicates that leucine-rich repeat kinase 2 (LRRK2) controls multiple processes in neurons and glia cells. Deregulated LRRK2 activity due to gene mutation represents the most common cause of autosomal dominant Parkinson's disease (PD). Protein...
Articles
Biochem Soc Trans (2005) 33 (4): 586–590.
Published: 01 August 2005
..., including α-synuclein, parkin, ubiquitin C-ter-minal hydrolase L1, oncogene DJ-1, PTEN-induced protein kinase 1 and microtubule-associated protein tau. Most recently, heterozygous mutations in LRRK2 (leucine-rich repeat kinase 2) were found to cause late-onset, autosomal-dominant PD. Despite...